Related Experiment Video
Updated: Mar 29, 2026

08:27
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
Published on: December 6, 2024
732
PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage
Leslie W Chan1, Chae Hwa Kim2, Xu Wang3
1Department of Bioengineering and Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195, USA.
Acta Biomaterialia
|November 24, 2015
Summary
New PolySTAT/chitosan gauzes enhance hemostasis by improving blood absorption and clotting. These advanced hemostatic materials reduce blood loss and improve survival rates in traumatic injury models.
Area of Science:
- Biomaterials Science
- Hemostasis Research
- Trauma Medicine
Background:
- Blood loss is a leading cause of death in traumatic injuries.
- Current chitosan-based hemostatic gauzes show variable performance under high arterial pressure.
- Enhanced stabilization of red blood cell aggregates is needed for improved hemostasis.
Purpose of the Study:
- To develop and evaluate PolySTAT/chitosan gauzes with enhanced hemostatic efficacy.
- To investigate the mechanism of fibrin cross-linking on chitosan fibers for improved clot stabilization.
- To compare the performance of PolySTAT/chitosan gauzes against existing hemostatic agents.
Main Methods:
- Impregnation of nonwoven chitosan gauze with PolySTAT, a synthetic polymer.
- Characterization of PolySTAT/chitosan gauze properties (fiber size, morphology, pore size).
- Evaluation of hemostatic efficacy in a rat model of femoral artery injury.
Main Results:
- PolySTAT/chitosan gauzes exhibited more rapid blood absorption than Celox® Rapid.
- Reduced blood loss and improved survival rates were observed in the rat model.
- PolySTAT/chitosan gauzes required less saline infusion, indicating better control of bleeding.
Conclusions:
- PolySTAT/chitosan gauzes offer improved hemostatic efficacy through enhanced blood clotting and fibrin cross-linking.
- These novel biomaterials demonstrate potential for managing severe bleeding in traumatic injuries.
- The combination of chitosan and PolySTAT provides a mechanically reinforced hemostatic plug.
Related Concept Videos
Introduction to Hemostasis
16.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
16.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Extrinsic and Intrinsic Pathways of Hemostasis
15.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.3K

